Connect with us

Hi, what are you looking for?

Economy

Concentrix readies vaccination plan for staff nationwide

OUTSOURCING firm Concentrix Philippines plans to offer coronavirus disease 2019 (COVID-19) vaccinations to its 100,000 staff nationwide.

The company has put in an initial order of 50,000 doses from pharmaceutical firm AstraZeneca, half of which will be donated to priority sectors identified by the government.

The AstraZeneca vaccine was found to have an efficacy rate as high as 90% in a smaller trial group that initially received half a dose, but as low as 62% among the majority given two full shots.

Private companies and local government units have signed an agreement to secure 17 million doses from the drugmaker as the Philippines tries to get 148 million COVID-19 vaccine doses to inoculate 50-70 million Filipinos this year.

Business process outsourcing (BPO) was one of the sectors allowed to have limited office operations during the stricter lockdown that started in March, provided that the companies apply social distancing measures and provide temporary accommodation.

“We will have it as soon as the Philippine government authorities are able to get it into the country,” Concentrix Senior Vice-President and Philippines Country Leader Amit Jagga said in a statement on Tuesday.

“As other vaccines are approved and as we get access to them, we are committed to continue to provide them for free to our staff.”

Alorica Philippines, another outsourcing firm, is ordering 80,000 doses for its employees and other Filipinos.

The Trade department said that it was gathering information from various groups like small and medium-sized enterprises that want to buy vaccines so that their requirements can be included among government orders. — Jenina P. Ibañez

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest

Investing

Elon Musk has suggested that he could seek to pay a lower price for Twitter, as the social media company’s would-be owner expressed further...

Investing

Tens of thousands of apprenticeships could be created and hundreds of millions of pounds saved if the flawed apprenticeships levy were reformed, according to...

Economy

The man accused of killing a doctor and wounding five other people in a shooting at a Taiwanese-American church banquet in California methodically planned the attack because he was upset over Chinese-Taiwanese tensions,...

Investing

Workers should “think and reflect” on whether to ask for pay rises because they risk fuelling inflation, the governor of the Bank of England...

Investing

Ofgem has come under fire for extending rules that will effectively prevent energy suppliers from offering deals that are significantly cheaper than the price...

Investing

Working from home is more popular in Britain than in continental Europe and North America, with commuting journeys down by more than a fifth...

You May Also Like

Investing

Having a good Instagram marketing agency to back up your Instagram account is an absolute must going into the new year. With competition stronger...

Economy

Ivermectin, an existing drug against parasites including head lice, has had a checkered history when it comes to treating COVID-19. The bulk of studies...

Investing

Insomnia is the most common sleep disorder in the global population. Therefore, it is a problem that many people suffer or have suffered throughout...

Investing

As a traditionally rigid insurance industry becomes bogged down by antiquated processes and operations, a handful of industry leaders are seeking to shake things...

Disclaimer: SmartRetirementReport.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2021 SmartRetirementReport. All Rights Reserved.